Software & Developer Tools
Artios Pharma
United Kingdomartios.com
Artios Pharma is a series c plus startup. 2 investors tracked.
Activeseries-c-plus
series-c-plus
Stage
2015
Founded
3
Investors
About Artios Pharma
Artios Pharma is a startup founded in 2015 based in the United Kingdom. Its most recent tracked round is Series C+. Brouky classifies it under Software & Developer Tools. Brouky records 3 investors associated with the company.
Artios Pharma is a clinical-stage biopharmaceutical company focused on developing DNA damage response (DDR)-based therapeutics for cancer treatment, specializing in small-molecule inhibitors targeting DDR pathways such as ATR and Pol Theta to treat challenging solid tumors.
Explore Artios Pharma's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.